Found 8 matching trials
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
PHASE2The main purpose of this study is to evaluate the safety and effectiveness ...
Location
Valleywise Health Medical Center
Study of MORF 057 to Evaluate Single and Multi Ascending Doses in Healthy Volunteers
PHASE1Phase 1a randomized, double-blind, placebo-controlled study to evaluate sin...
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
PHASE2This is a Phase 2, randomized, double-blind, placebo-controlled, multicente...
Location
Gastro Care Institute
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
PHASE2The main purpose of the study is to evaluate the effectiveness and safety o...
Location
Mayo Clinic in Arizona - Scottsdale
A Study of LY4268989 (MORF-057) in Healthy Participants
PHASE1The purpose of this study is to measure the body's absorption and processin...
A Study of LY4268989 (MORF 057) in Healthy Participants
PHASE1The purpose of this study is to identify if two different tablets of LY4268...
Location
Fortrea Clinical Research Unit
A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC
PHASE2This is an open-label, single arm, multicenter, Phase 2a study evaluating t...
Location
Clinical Study Site
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
PHASE2This is a Phase 2b randomized, double-blind, placebo-controlled study to ev...
Status
Active Not Recruiting
Location
Arizona Digestive Health - Sun City